Paydirt
LI
Insider

Lilly Endowment Inc

Other

Lilly Endowment Inc (Other) filed 35 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 35 sales, 1 filed past the two-business-day deadline), most often in Eli Lilly and Company (LLY). The largest single filing was $75.9B of LLY (178,295 sh across 4 lots, as filed), executed Nov 14 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
35
0 buys · 35 sells · 1 late
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$79.3B
shares × price, as filed
Last traded
May 6
Filed May 7

Median ADV $3.8B across their filed names

Open performance
Volume by month
$78.0B$39.0B$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · sells $2.2BMar 2025 · sells $204.3MJul 2025 · sells $225.4MSep 2025 · sells $99.6MOct 2025 · sells $883.3MNov 2025 · sells $78.0BDec 2025 · sells $7.0MJan 2026 · sells $323.9MMay 2026 · sells $15.8M
Buys $0 Sells $82.0B

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 34 filings

Sector per market data · by filing · past 12 months

Most traded names
LLY Eli Lilly and Company LLY · 0 buys · 45 sells 45 filings
Recent filings
LLYSALE Eli Lilly and Company View filing → $152.1M
142,307 sh across 6 lots
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET
LLYSALE Eli Lilly and Company View filing → $111.5M
105,326 sh across 17 lots
Exec Nov 21 2025
Filed Nov 24 2025 · 5:30 PM ET
LLYSALE Eli Lilly and Company View filing → $39.1M
37,148 sh across 6 lots
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET
LLYSALE Eli Lilly and Company View filing → $176.1M
167,526 sh across 6 lots
Exec Nov 19 2025
Filed Nov 20 2025 · 5:30 PM ET
LLYSALE Eli Lilly and Company View filing → $62.3M
60,213 sh across 10 lots
Exec Nov 18 2025
Filed Nov 19 2025 · 5:30 PM ET
LLYSALE Eli Lilly and Company View filing → $10.2M
9,886 sh across 2 lots
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET
LLYSALE Eli Lilly and Company View filing → $75.9B
178,295 sh across 4 lots
Exec Nov 14 2025
Filed Nov 17 2025 · 5:30 PM ET
LLYSALE Eli Lilly and Company View filing → $48.0M
46,606 sh across 2 lots
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET
More filings →